Pregabalin and gabapentin to be reclassified as Class C controlled substances Following a public consultation and advice from the Advisory Council on the Misuse of Drugs, gabapentinoids are to be reclassified following concerns over misuse. Gabapentin is an anticonvulsant drug also used to treat certain types of pain. According to the federal government, gabapentin isn’t a controlled substance. Tweet Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from next April, the government announced today (15 October). Today’s move comes after experts highlighted rising numbers of fatalities linked to the drugs. See Epilepsy. MHRA/CHM advice: Gabapentin (Neurontin ®) and risk of abuse and dependence: new scheduling requirements from 1 April (April 2019) Following concerns about abuse, gabapentin has been reclassified as a Class C controlled substance and is now a Schedule 3 drug, but is exempt from safe custody requirements. From 1 April 2019 pregabalin and gabapentin will be reclassified as class C controlled substances in the UK. The change, announced in October 2018, is expected to prompt a decline in the use of the drugs as prescribing, dispensing, and collecting them becomes more onerous for doctors, pharmacists, and patients. The reclassification will make it illegal to supply pregabalin and gabapentin Gabapentin is a controlled medicine. This means there are strict rules on how it's prescribed and dispensed to make sure it's not given to the wrong person or misused. When you collect gabapentin, your pharmacist will ask for proof of identity such as your passport or driving licence. The harms associated with pregabalin and gabapentin are commensurate with that of other substances controlled under the Misuse of Drugs Act 1971. The abuse and potential for abuse of pregabalin and gabapentin is similar to that of tramadol14, (controlled as Class C under the Misuse of Drugs Act 1971). The most commonly encountered drugs currently controlled under the misuse of drugs legislation. Pregabalin and gabapentin will be reclassified as class C controlled substances in the UK from next April to reduce the growing number of deaths associated with their misuse, the government has said.1 Victoria Atkins, parliamentary under secretary for crime, safeguarding, and vulnerability, said, “Any death related to the misuse of drugs is a tragedy. We accepted expert advice and will now As of 1 April 2019, pregabalin and gabapentin are controlled under the Misuse of Drugs Act 1971 as Class C substances and scheduled under the Misuse of Drugs Regulations 2001 as Schedule 3 Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from next April, the government announced today (15 October). The UK government reclassified gabapentin and pregabalin as ‘controlled drugs’ from April 2019. This study aimed to describe the trends in gabapentinoid prescribing before and immediately after reclassification, in the UK Clinical Practice Research Datalink, an electronic primary care health record broadly representative of the UK. Gabapentin and pregabalin – controlled drugs demystified Gabapentin and pregabalin were reclassified as controlled drugs (CDs) back in April 2019, yet many health and social care providers still seem unsure how to treat them. Are they controlled drugs? es make people feel like elly, didn’t know what happened.” “That’s one of my last overdoses. I knew the heroin was strong controlled drugs • Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from April 2019. remember the S.M. Service is here to help The ACMD recommended that gabapentin and pregabalin be controlled as Class C drugs under the 1971 Act, and placed in Schedule 3 to the 2001 Regulations. The UK government is to reclassify the prescription drug pregabalin as a class C controlled substance, after experts issued safety warnings following an increase in deaths linked to its use. A Home Office consultation, which also proposes reclassifying gabapentin, has been launched in response to growing pressure for the drug to be reclassified to tackle misuse and addiction. Last year the The UK government announced last week that the medicines pregabalin and gabapentin will be reclassified as class C under the Misuse of Drugs Act 1971. The change will take place in April 2019. Class C is the third in the government’s three-tier system for categorising controlled substances. In October 2018, the United Kingdom (UK) reclassified pregabalin and gabapentin as class C controlled drugs, which will come into force in April 2019.1 This is in direct response to the increased number of deaths linked to both these drugs in the UK and a consultation process around this issue.2 Speaking of the announcement, the British Minister for Crime, Safeguarding and Vulnerability Gabapentin and pregabalin have been reclassified by the Home Office as class C controlled substances. The widely prescribed drugs, licensed to treat epilepsy, anxiety, peripheral and neuropathic pain (pain caused by damage or injury to the nerves) are now subject to increased controls in the UK.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |